Amicus Therapeutics
FOLD
FOLD
227 hedge funds and large institutions have $4.71B invested in Amicus Therapeutics in 2023 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 97 increasing their positions, 64 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
10% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 29
9.28% more ownership
Funds ownership: 104.01% → 113.29% (+9.3%)
0% more funds holding
Funds holding: 227 → 227 (0)
Holders
227
Holding in Top 10
8
Calls
$51.8M
Puts
$11.3M
Top Buyers
| 1 | +$226M | |
| 2 | +$109M | |
| 3 | +$79.9M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$68.7M |
| 5 |
Blackstone Inc
New York
|
+$35M |
Top Sellers
| 1 | -$48.6M | |
| 2 | -$30M | |
| 3 | -$28.9M | |
| 4 |
BC
Boxer Capital
San Diego,
California
|
-$28.3M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$26M |